Free Trial

KeyCorp's Rating of Exagen on 3/11/2026

On March 11, 2026, KeyCorp updated its outlook on Exagen (NASDAQ:XGN) with the action "Lower Price Target", setting a price target of $10.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from KeyCorp

DateCompanyAction
10/16/2026
Fox Corporation stock logo
FOXA
FOX
Downgrade
10/16/2026
Waystar Holding Corp. stock logo
WAY
Waystar
Boost Price Target
10/16/2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
Boost Price Target
10/16/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price Target
10/16/2026
CrowdStrike stock logo
CRWD
CrowdStrike
Reiterated Rating
10/16/2026
eToro Group Ltd. stock logo
ETOR
eToro Group
Lower Price Target
More Ratings From KeyCorp